Abstract:Objective To evaluate the clinical efficacy of bilirubin adsorption in patients with hyperbilirubinemia. Methods A total of 10 patients with hyperbilirubinemia who underwent bilirubin adsorption therapy at the Blood Purification Center of Xiangya Hospital, Central South University from 2015 to 2017 were enrolled. Among them, 8 were male and 2 were female; the average age was (57 ± 18) years. Results A total of 18 bilirubin treatments were performed in 10 patients. Among them, 1 was markedly effective, 8 was effective, and 2 were ineffective. The total effective rate was 80%. After treatment, bilirubin decreased (p < 0.05), which had no effect on the clearance of transaminase, creatinine, urea, uric acid (p > 0.05), and had no effect on albumin, blood routine, coagulation routine, e7A (p > 0.05). Conclusions The bilirubin adsorption is effective and safe in the treatment of hyperbilirubinemia patients with elevated serum bilirubin. If a critically ill patient with complications such as spontaneous peritonitis, hepatorenal syndrome, or hepatic encephalopathy is combined, multiple artificial liver treatment modes should be combined.